Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Astute Medical has raised $6.25 million in an initial financing round led by De Novo Ventures.
Subscribe to our email newsletter
The proceeds will primarily be used to fund R&D aimed at the identification and validation of protein biomarkers with the goal of finding high potential diagnostic candidates.
Christopher Hibberd, Astute Medical’s CEO, said: “This investment is an exciting event that lays the foundation for our R&D activities. We believe the participation of our lead investor De Novo Ventures demonstrates confidence in our ability to develop innovative diagnostic tests for use in acute hospital settings.”